Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for DuPont de Nemours (NYSE:DD) Stock

DuPont de Nemours (NYSE:DD) had its target price hoisted by equities research analysts at Deutsche Bank Aktiengesellschaft from $58.00 to $60.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The brokerage currently has a “buy” rating on the basic materials company’s stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 20.63% from the stock’s current price.

A number of other research analysts have also recently weighed in on DD. Wolfe Research lifted their target price on shares of DuPont de Nemours from $49.00 to $54.00 and gave the company an “outperform” rating in a research note on Wednesday, February 11th. Weiss Ratings reiterated a “sell (d)” rating on shares of DuPont de Nemours in a research note on Friday, March 27th. Wall Street Zen raised DuPont de Nemours to a “hold” rating in a report on Saturday, January 10th. Zacks Research downgraded DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Royal Bank Of Canada dropped their price objective on DuPont de Nemours from $60.00 to $56.00 and set an “outperform” rating for the company in a research note on Friday, April 24th. Twelve investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, DuPont de Nemours presently has a consensus rating of “Moderate Buy” and a consensus price target of $54.93.

DuPont de Nemours Trading Up 2.8%

DuPont de Nemours stock opened at $49.74 on Thursday. The firm has a 50 day moving average of $46.41 and a 200 day moving average of $43.37. The firm has a market capitalization of $20.39 billion, a price-to-earnings ratio of -828.81, a P/E/G ratio of 1.54 and a beta of 1.02. DuPont de Nemours has a 12-month low of $27.16 and a 12-month high of $52.66. The company has a current ratio of 2.68, a quick ratio of 1.91 and a debt-to-equity ratio of 0.22.

DuPont de Nemours (NYSE:DD) last released its earnings results on Tuesday, May 5th. The basic materials company reported $0.55 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.07. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. DuPont de Nemours had a negative net margin of 0.30% and a positive return on equity of 7.15%. The firm’s revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the business earned $1.03 EPS. DuPont de Nemours has set its Q2 2026 guidance at 0.590-0.590 EPS and its FY 2026 guidance at 2.350-2.400 EPS. As a group, research analysts predict that DuPont de Nemours will post 2.4 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Palisade Asset Management LLC bought a new position in DuPont de Nemours during the third quarter valued at approximately $26,000. Financial Life Planners purchased a new position in DuPont de Nemours during the 3rd quarter valued at approximately $27,000. Imprint Wealth LLC bought a new stake in DuPont de Nemours in the 3rd quarter worth approximately $27,000. Measured Wealth Private Client Group LLC purchased a new stake in shares of DuPont de Nemours during the 3rd quarter worth approximately $30,000. Finally, Crews Bank & Trust raised its holdings in shares of DuPont de Nemours by 55.8% during the 3rd quarter. Crews Bank & Trust now owns 508 shares of the basic materials company’s stock worth $40,000 after acquiring an additional 182 shares in the last quarter. Hedge funds and other institutional investors own 73.96% of the company’s stock.

DuPont de Nemours Company Profile

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.